These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18176322)

  • 1. Infections prevented by increasing HIV serostatus awareness in the United States, 2001 to 2004.
    Pinkerton SD; Holtgrave DR; Galletly CL
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):354-7. PubMed ID: 18176322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can increasing awareness of HIV seropositivity reduce infections by 50% in the United States?
    Holtgrave DR; Pinkerton SD
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):360-3. PubMed ID: 17159653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.
    Marks G; Crepaz N; Janssen RS
    AIDS; 2006 Jun; 20(10):1447-50. PubMed ID: 16791020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Jersey's HIV exposure law and the HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV.
    Galletly CL; Glasman LR; Pinkerton SD; Difranceisco W
    Am J Public Health; 2012 Nov; 102(11):2135-40. PubMed ID: 22994175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral factors in assessing impact of HIV treatment as prevention.
    Holtgrave DR; Maulsby C; Wehrmeyer L; Hall HI
    AIDS Behav; 2012 Jul; 16(5):1085-91. PubMed ID: 22491813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a behavioral intervention for seropositive youth.
    Lee MB; Leibowitz A; Rotheram-Borus MJ
    AIDS Educ Prev; 2005 Apr; 17(2):105-18. PubMed ID: 15899749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia.
    Abel-Ollo K; Rahu M; Rajaleid K; Talu A; Ruutel K; Platt L; Bobrova N; Rhodes T; Uuskula A
    AIDS Care; 2009 Jul; 21(7):851-7. PubMed ID: 20024741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discussing HIV serostatus with prospective sex partners: a potential HIV prevention strategy among high-risk men who have sex with men.
    Rietmeijer CA; Lloyd LV; McLean C
    Sex Transm Dis; 2007 Apr; 34(4):215-9. PubMed ID: 17179774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of interventions promoting HIV serostatus disclosure to sexual partners: a systematic review.
    Conserve DF; Groves AK; Maman S
    AIDS Behav; 2015 Oct; 19(10):1763-72. PubMed ID: 25645328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
    Holtgrave DR
    PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing HIV transmission rates to assist in prioritizing HIV prevention services.
    Holtgrave DR; Anderson T
    Int J STD AIDS; 2004 Dec; 15(12):789-92. PubMed ID: 15601483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?
    Pinkerton SD
    AIDS; 2007 Jul; 21(12):1625-9. PubMed ID: 17630558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.S. HIV Incidence and Transmission Goals, 2020 and 2025.
    Bonacci RA; Holtgrave DR
    Am J Prev Med; 2017 Sep; 53(3):275-281. PubMed ID: 28522237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partner serostatus and disclosure stigma: implications for physical and mental health outcomes among HIV-positive adults.
    Golub SA; Tomassilli JC; Parsons JT
    AIDS Behav; 2009 Dec; 13(6):1233-40. PubMed ID: 18843532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic Trends in New HIV Diagnoses in the U.S., 2009-2013.
    Bonacci RA; Holtgrave DR
    Am J Prev Med; 2016 Dec; 51(6):1044-1050. PubMed ID: 27567238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs.
    Marks G; Crepaz N; Senterfitt JW; Janssen RS
    J Acquir Immune Defic Syndr; 2005 Aug; 39(4):446-53. PubMed ID: 16010168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serosorting can potentially increase HIV transmissions.
    Butler DM; Smith DM
    AIDS; 2007 May; 21(9):1218-20. PubMed ID: 17502737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.
    Jenness SM; Goodreau SM; Rosenberg E; Beylerian EN; Hoover KW; Smith DK; Sullivan P
    J Infect Dis; 2016 Dec; 214(12):1800-1807. PubMed ID: 27418048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living serodiscordantly in Papua New Guinea: sexual practices of HIV-positive people on ART by serostatus of regular heterosexual partner.
    Kelly A; Kupul M; Frankland A; Worth H; Nosi S; Mek A; Kepa B; Walizopa L; Emori R; Pirpir L; Akuani F; Cangah B; Siba P
    AIDS Care; 2011 Jun; 23(6):734-40. PubMed ID: 21390883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-infected women and sexual risk reduction: the relevance of existing models of behavior change.
    Kline A; VanLandingham M
    AIDS Educ Prev; 1994 Oct; 6(5):390-402. PubMed ID: 7818975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.